- Anti-histamines
- Steroids
- Beta-agonists
- Immunotherapy Drugs
Grass Pollen Allergy Treatment Market size was valued at 26,206.6 million in 2022 and is expected to reach 40,192.3 million by 2029, at a CAGR of 6.3% during the forecast period 2023 to 2029. Pollens are the tiny particles released by plants, trees, and grasses as a part of reproductive cycle in summer and spring seasons. Pollens inhaled by animals and humans can cause inflammation and irritation. Hay fever and allergic rhinitis are the commonly caused allergies due to grass pollen. Symptoms associated with grass pollen Allergy Treatment include running or blocked nose, frequent sneezing, itchy throat and nose among others. Pollens are microscopic particles emitted by trees, plants, and grasses as part of their reproductive cycle throughout the spring and summer. Pollen is easily swallowed by humans and animals because to its small particles, which can cause considerable irritation and inflammation in some people. Allergic rhinitis, sometimes known as hay fever, is one of the most prevalent allergies induced by grass pollen. According to a study published in 2010 by the American College of Allergy, Asthma & Immunology, around 16.9 million adults and 6.7 million children were diagnosed with hay fever, and the prevalence of the disease is increasing by about 30% in adults and 40% in children. Hay fever symptoms affect 500 million people in the United States and around the world.
The Grass Pollen Allergy Treatment Market Key development:
- In February 2018, ASIT Biotech raised $ 13.9 Mn in funding for the Phase III clinical development of GP-ASIT+ used for grass pollen rhinitis
Grass Pollen Allergy Treatment Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.3%
Largest Market
North-America
Fastest Growing Market
North America
Grass Pollen Allergy Treatment Market Dynamics
Rise in prevalence of grass pollen allergy treatment especially hay fever, increase in R&D for innovation of newer drugs for gross pollen allergy treatment, promising pipeline drugs for the treatment, rise in adoption of ornamental crops and grass farming in the residential areas, and grow in healthcare expenditure are anticipated to fuel the global grass pollen allergy treatment market over the forecast years. However, lack of permanent treatment for grass pollen allergy treatment and less number of existed drugs in the market are expected to restrain the growth of global grass pollen market.
North-America Got Significant Share
Grass Pollen Allergy Treatment Market
Geographically, global grass pollen allergy treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America grass pollen allergy treatment marketis poised to grow at healthy growth rate owing to rise in funding for the research activities, frequent launching of newer drugs, and government initiations for the grass pollen allergy treatment are witnessed to propel the market. Europe grass pollen allergy treatment market has lucrative growth attributed to increase in the incidence of grass pollen allergies, adoption newer therapeutic drugs, and increase in healthcare expenditure are anticipated to bolster the market. However, Asia Pacific grass pollen allergy treatment market is poised to grow due to entry of market players into Asia Pacific countries, increase in the agriculture farming leads to rise in prevalence of grass pollen allergies, and rise in R&D expenditure expected to create demand for pollen allergy treatment market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Grass Pollen Allergy Treatment Market Segmentation
By Drug class
By Route Administration
- Oral
- Parenteral
- Inhalation
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Frequently Asked Questions
The grass pollen allergy treatment market is projected to expand at a CAGR of 6.3% during the forecast period
Allergy Treatment Therapeutics Plc, ALK-Abello A/S, Biomay AG, Circassia Holdings Ltd, Allergopharma Joachim Ganzer KG
North America is the fastest-growing region for the grass pollen allergy treatment market
Grass Pollen Allergy Treatment Market size was valued at 26,206.6 million in 2022 and is expected to reach 40,192.3 million by 2029
Table of Content
- Executive Summary
- Global Grass Pollen Allergy Treatment Market Introduction
- Global Grass Pollen Allergy Treatment Market - Taxonomy
- Global Grass Pollen Allergy Treatment Market - Definitions
- Drug Class
- Route of Administration
- Distribution Channel
- Global Grass Pollen Allergy Treatment Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Grass Pollen Allergy Treatment Market Dynamic Factors - Impact Analysis
- Global Grass Pollen Allergy Treatment Market - Competition Landscape
- Epidemiology
- Global Grass Pollen Allergy Treatment Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%)
- Market OpportunityAnalysis
- Global Grass Pollen Allergy Treatment Market, By Drug Class, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Anti-histamines
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Steroids
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Beta-agonists
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Immunotherapy Drugs
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Anti-histamines
- Global Grass Pollen Allergy Treatment Market Forecast, By Route of Administration,2018 - 2022 and Forecast, 2023 - 2029
- Oral
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Parenteral
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Inhalation
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Oral
- Global Grass Pollen Allergy Treatment Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Hospital Pharmacies
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Retail Pharmacies
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Online Pharmacies
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Hospital Pharmacies
- Global Grass Pollen Allergy Treatment Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- North America
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Europe
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Asia-Pacific
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Latin America
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Middle East and Africa
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Global Grass Pollen Allergy Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Region, 2023 - 2029
- North America
- North America Grass Pollen Allergy Treatment Market Analysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Anti-histamines
- Steroids
- Beta-agonists
- Immunotherapy Drugs
- Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Oral
- Parenteral
- Inhalation
- Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- S.
- Canada
- North America Grass Pollen Allergy Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country, 2023 - 2029
- North America Grass Pollen Allergy Treatment Market Dynamics - Trends
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Europe Grass Pollen Allergy Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Anti-histamines
- Steroids
- Beta-agonists
- Immunotherapy Drugs
- Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Oral
- Parenteral
- Inhalation
- Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Poland
- Rest of Europe
- Europe Grass Pollen Allergy Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country,2023 - 2029
- Europe Grass Pollen Allergy Treatment Market Dynamics - Trends
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Asia-Pacific Grass Pollen Allergy Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Anti-histamines
- Steroids
- Beta-agonists
- Immunotherapy Drugs
- Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Oral
- Parenteral
- Inhalation
- Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Japan
- China
- India
- ASEAN
- Australia & New Zealand
- Rest of Asia-Pacific
- Asia-Pacific Grass Pollen Allergy Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country,2023 - 2029
- Asia-Pacific Grass Pollen Allergy Treatment Market Dynamics - Trends
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Latin America Grass Pollen Allergy Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Anti-histamines
- Steroids
- Beta-agonists
- Immunotherapy Drugs
- Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Oral
- Parenteral
- Inhalation
- Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Latin America Grass Pollen Allergy Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country,2023 - 2029
- Latin America Grass Pollen Allergy Treatment Market Dynamics - Trends
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Middle East and Africa Grass Pollen Allergy Treatment Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Anti-histamines
- Steroids
- Beta-agonists
- Immunotherapy Drugs
- Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Oral
- Parenteral
- Inhalation
- Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
- MEA Grass Pollen Allergy Treatment Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Channel and Country,2023 - 2029
- MEA Grass Pollen Allergy Treatment Market Dynamics - Trends
- Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
- Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
- Allergy Treatment Therapeutics Plc (UK)
- ALK-Abello A/S (Denmark)
- Biomay AG (Austria)
- Circassia Holdings Ltd. (UK)
- Allergopharma Joachim Ganzer KG (Germany)
- Anergis SA (Switzerland)
- Laboratorios LETI S.L (Spain)
- HAL Allergy Treatment BV (Netherlands)
- Regeneron Pharmaceuticals Inc (U.S.)
- ASIT Biotech SA (Belgium)
- Research Methodology
- Key Assumptions and Acronyms
- Allergy Treatment Therapeutics Plc (UK)
- ALK-Abello A/S (Denmark)
- Biomay AG (Austria)
- Circassia Holdings Ltd. (UK)
- Allergopharma Joachim Ganzer KG (Germany)
- Anergis SA (Switzerland)
- Laboratorios LETI S.L (Spain)
- HAL Allergy Treatment BV (Netherlands)
- Regeneron Pharmaceuticals Inc (U.S.)
- ASIT Biotech SA (Belgium)